For working-age cancer survivors, medical debt and bankruptcy create financial hardships

Health Affairs

Volumn 35, Issue 1, 2016, Pages 54-61

  Banegas, Matthew P ^a   Guy, Gery P ^b   de Moor, Janet S ^c   Ekwueme, Donatus U ^b   Virgo, Katherine S ^d   Kent, Erin E ^c   Nutt, Stephanie ^e   Zheng, Zhiyuan ^f   Rechis, Ruth ^e   Yabroff, K Robin ^c  

^a CENTER FOR HEALTH RESEARCH   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d EMORY UNIVERSITY   (United States)

^e LIVESTRONG Foundation   (United States)

^f AMERICAN CANCER SOCIETY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CANCER EPIDEMIOLOGY; CANCER SURVIVOR; FINANCIAL MANAGEMENT; HUMAN; MAJOR CLINICAL STUDY; PUBLIC HEALTH INSURANCE; ADOLESCENT; AGE; COST OF ILLNESS; ECONOMICS; FACTUAL DATABASE; FEMALE; HEALTH CARE SURVEY; MALE; MIDDLE AGED; NEOPLASMS; POVERTY; QUALITY OF LIFE; QUESTIONNAIRE; RISK ASSESSMENT; SOCIOECONOMICS; STATISTICS AND NUMERICAL DATA; SURVIVOR; UNITED STATES; WORK; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; BANKRUPTCY; COST OF ILLNESS; DATABASES, FACTUAL; FEMALE; HEALTH CARE SURVEYS; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; POVERTY; QUALITY OF LIFE; RISK ASSESSMENT; SOCIOECONOMIC FACTORS; SURVEYS AND QUESTIONNAIRES; SURVIVORS; UNITED STATES; WORK; YOUNG ADULT;

EID: 84958153317     PISSN: 02782715     EISSN: 15445208     Source Type: Journal    
DOI: 10.1377/hlthaff.2015.0830     Document Type: Article

References (50)

1. Institute of Medicine. Ensuring patient access to affordable cancer drugs: workshop summary. Washington (DC): National Academies Press; 2014.
2. Mariotto AB, Yabroff KR, Shao Y, Feuer EJ, Brown ML. Projections of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst. 2011;103(2):117-28.
3. Bach PB.Why drugs cost so much. New York Times. 2015 Jan 14.
4. Young RA, DeVoe JE.Who will have health insurance in the future? An updated projection. Ann Fam Med. 2012;10(2):156-62.
5. Guy GP Jr, Ekwueme DU, Yabroff KR, Dowling EC, Li C, Rodriguez JL, et al. Economic burden of cancer survivorship among adults in the United States. J Clin Oncol. 2013; 31(30):3749-57.
6. Zafar SY, Peppercorn JM, Schrag D, Taylor DH, Goetzinger AM, Zhong X, et al. The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient's experience. Oncologist. 2013;18(4): 381-90.
7. Ramsey S, Blough D, Kirchhoff A, Kreizenbeck K, Fedorenko C, Snell K, et al. Washington State cancer patients found to be at greater risk for bankruptcy than people without a cancer diagnosis. Health Aff (Millwood). 2013;32(6):1143-52.
8. Schwartz K, Claxton G, Martin K, Schmidt C. Spending to survive: cancer patients confront holes in the health insurance system [Internet]. Menlo Park (CA): Henry J. Kaiser Family Foundation; 2009 Feb [cited 2015 Nov 13]. Available from: https://kaiserfamilyfoundation.files.wordpress.com/2013/01/7851.pdf
9. Shankaran V, Jolly S, Blough D, Ramsey SD. Risk factors for financial hardship in patients receiving adjuvant chemotherapy for colon cancer: a population-based exploratory analysis. J Clin Oncol. 2012;30(14): 1608-14.
10. Kent EE, Forsythe LP, Yabroff KR, Weaver KE, de Moor JS, Rodriguez JL, et al. Are survivors who report cancer-related financial problems more likely to forgo or delay medical care? Cancer. 2013;119(20):3710-7.
11. Nekhlyudov L, Walker R, Ziebell R, Rabin B, Nutt S, Chubak J. Cancer survivors' experiences with insurance, employment, and personal finances: results from a multi-site study [Internet]. Poster presented at: 2015 American Society of Clinical Oncology Annual Meeting; 2015 May 29-Jun 2; Chicago, IL; [cited 2015 Nov 13]. Available from: http://meetinglibrary.asco.org/print/2002761
12. Meneses K, Azuero A, Hassey L, McNees P, Pisu M. Does economic burden influence quality of life in breast cancer survivors? Gynecol Oncol. 2012;124(3):437-43.
13. Himmelstein DU, Thorne D, Warren E, Woolhandler S. Medical bankruptcy in the United States, 2007: results of a national study. Am J Med. 2009;122(8):741-6.
14. Yabroff KR, Dowling EC, Guy GP Jr, Banegas MP, Davidoff A, Han X, et al. Financial hardship associated with cancer in the United States: findings from a population-based sample of adult cancer survivors. J Clin Oncol. 2015 Dec 17. [Epub ahead of print].
15. Ekwueme DU, Yabroff KR, Guy GP Jr, Banegas MP, de Moor JS, Li C, et al. Medical costs and productivity losses of cancer survivors-United States, 2008-2011. MMWR Morb Mortal Wkly Rep. 2014;63(23): 505-10.
16. Short PF, Vasey JJ, Belue R.Work disability associated with cancer survivorship and other chronic conditions. Psychooncology. 2008; 17(1):91-7.
17. Oberst K, Bradley CJ, Gardiner JC, Schenk M, Given CW.Work task disability in employed breast and prostate cancer patients. J Cancer Surviv. 2010;4(4):322-30.
18. Bradley CJ, Oberst K, Schenk M. Absenteeism from work: the experience of employed breast and prostate cancer patients in the months following diagnosis. Psychooncology. 2006;15(8):739-47.
19. Steiner JF, Cavender TA, Main DS, Bradley CJ. Assessing the impact of cancer on work outcomes: what are the research needs? Cancer. 2004; 101(8):1703-11.
20. Bradley CJ, Bednarek HL, Neumark D. Breast cancer survival, work, and earnings. J Health Econ. 2002;21(5): 757-79.
21. Bradley CJ, Neumark D, Luo Z, Schenk M. Employment and cancer: findings from a longitudinal study of breast and prostate cancer survivors. Cancer Invest. 2007;25(1):47-54.
22. Bradley CJ, Neumark D, Luo Z, Bednarek H, Schenk M. Employment outcomes of men treated for prostate cancer. J Natl Cancer Inst. 2005;97(13):958-65.
23. Moran JR, Short PF, Hollenbeak CS. Long-term employment effects of surviving cancer. J Health Econ. 2011;30(3):505-14.
24. Farley Short P, Bradley CJ, Yabroff KR. Employment status among cancer survivors. JAMA. 2009;302(1): 33; author reply 34-5.
25. Yabroff KR, Lawrence WF, Clauser S, Davis WW, Brown ML. Burden of illness in cancer survivors: findings from a population-based national sample. J Natl Cancer Inst. 2004; 96(17):1322-30.
26. Bestvina CM, Zullig LL, Rushing C, Chino F, Samsa GP, Altomare I, et al. Patient-oncologist cost communication, financial distress, and medication adherence. J Oncol Pract. 2014;10(3):162-7.
27. Zullig LL, Peppercorn JM, Schrag D, Taylor DH Jr, Lu Y, Samsa G, et al. Financial distress, use of cost-coping strategies, and adherence to prescription medication among patients with cancer. J Oncol Pract. 2013; 9(6 Suppl):60s-3s.
28. Jagsi R, Pottow JAE, Griffith KA, Bradley C, Hamilton AS, Graff J, et al. Long-term financial burden of breast cancer: experiences of a diverse cohort of survivors identified through population-based registries. J Clin Oncol. 2014;32(12):1269-76.
29. Irwin B, Kimmick G, Altomare I, Marcom PK, Houck K, Zafar SY, et al. Patient experience and attitudes toward addressing the cost of breast cancer care. Oncologist. 2014;19(11):1135-40.
30. Veenstra CM, Regenbogen SE, Hawley ST, Griggs JJ, Banerjee M, Kato I, et al. A composite measure of personal financial burden among patients with stage III colorectal cancer. Med Care. 2014;52(11): 957-62.
31. Short PF, Moran JR, Punekar R. Medical expenditures of adult cancer survivors aged <65 years in the United States. Cancer. 2011;117(12): 2791-800.
32. Finkelstein EA, Tangka FK, Trogdon JG, Sabatino SA, Richardson LC. The personal financial burden of cancer for the working-aged population. Am J Manag Care. 2009;15(11): 801-6.
33. Yabroff KR, Dowling E, Rodriguez J, Ekwueme DU, Meissner H, Soni A, et al. The Medical Expenditure Panel Survey (MEPS) Experiences with Cancer Survivorship Supplement. J Cancer Surviv. 2012;6(4):407-19.
34. Agency for Healthcare Research and Quality. Medical Expenditure Panel Survey: cancer SAQ pretest reports for 2011 survey year [Internet]. Rockville (MD): AHRQ; [cited 2015 Nov 13]. Available from: http://meps.ahrq.gov/mepsweb/survey_comp/cncr_prtst_report_2011.shtml
35. Shankaran V, Ramsey S. Addressing the financial burden of cancer treatment: from copay to can't pay. JAMA Oncol. 2015;1(3):273-4.
36. Blumberg LJ, Waidmann TA, Blavin F, Roth J. Trends in health care financial burdens, 2001 to 2009. Milbank Q. 2014;92(1):88-113.
37. American Society of Clinical Oncology. The state of cancer care in America, 2015: a report by the American Society of Clinical Oncology. J Oncol Pract. 2015;11(2): 79-113.
38. Cunningham PJ. Trade-offs getting tougher: problems paying medical bills increase for U.S. families, 2003-2007. Track Rep. 2008(21): 1-5.
39. Doty MM, Edwards JN, Holmgren AL. Seeing red: Americans driven into debt by medical bills: results from a national survey [Internet]. New York (NY): Commonwealth Fund; 2005 Aug [cited 2015 Nov 16]. (Issue Brief). Available from: http://www.commonwealthfund.org/usr_doc/837_Doty_seeing_red_medical_debt.pdf?section=4039
40. Cunningham PJ. The share of people with high medical costs increased prior to implementation of the Affordable Care Act. Health Aff (Millwood). 2015;34(1):117-24.
41. Himmelstein DU, Warren E, Thorne D, Woolhandler S. Illness and injury as contributors to bankruptcy. Health Aff (Millwood). 2005;24(2): w5-63-73. DOI: 10.1377/hlthaff.w5.63.
42. Bernard DS, Farr SL, Fang Z. National estimates of out-of-pocket health care expenditure burdens among nonelderly adults with cancer: 2001 to 2008. J Clin Oncol. 2011;29(20):2821-6.
43. Davidoff AJ, Erten M, Shaffer T, Shoemaker JS, Zuckerman IH, Pandya N, et al. Out-of-pocket health care expenditure burden for Medicare beneficiaries with cancer. Cancer. 2013;119(6):1257-65.
44. Davidoff AJ, Hill SC, Bernard D, Yabroff KR. The Affordable Care Act and expanded insurance eligibility among nonelderly adult cancer survivors. J Natl Cancer Inst. 2015; 107(9).
45. Meropol NJ, Schrag D, Smith TJ, Mulvey TM, Langdon RM Jr, Blum D, et al. American Society of Clinical Oncology guidance statement: the cost of cancer care. J Clin Oncol. 2009;27(23):3868-74.
46. Dusetzina SB, Winn AN, Abel GA, Huskamp HA, Keating NL. Cost sharing and adherence to tyrosine kinase inhibitors for patients with chronic myeloid leukemia. J Clin Oncol. 2014;32(4):306-11.
47. Goldman DP, Jena AB, Lakdawalla DN, Malin JL, Malkin JD, Sun E. The value of specialty oncology drugs. Health Serv Res. 2010;45(1):115-32.
48. Kaisaeng N, Harpe SE, Carroll NV. Out-of-pocket costs and oral cancer medication discontinuation in the elderly. J Manag Care Spec Pharm. 2014;20(7):669-75.
49. Streeter SB, Schwartzberg L, Husain N, Johnsrud M. Patient and plan characteristics affecting abandonment of oral oncolytic prescriptions. J Oncol Pract. 2011;7(3 Suppl): 46s-51s.
50. Goodell S, Swartz K. Cost-sharing: effects on spending and outcomes [Internet]. Princeton (NJ): Robert Wood Johnson Foundation; 2010 Dec [cited 2015 Nov 16]. (Policy Brief No. 20). Available for download from: http://www.rwjf.org/en/library/research/2011/12/costsharing-effects-on-spending-andoutcomes. html